Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling

Journal of Hepatology

Volumn 55, Issue 4, 2011, Pages 866-875

  Bergé, Mathieu ^a,b   Allanic, David ^a,b   Bonnin, Philippe ^b,c   De Montrion, Catherine ^e   Richard, Johann ^e   Suc, Michel ^e   Boivin, Jean Franois ^e   Contrers, Jean Olivier ^a,b   Lockhart, Brian P ^e   Pocard, Marc ^b,c   Lévy, Bernard I ^a,b,c,d   Tucker, Gordon C ^e   Tobelem, Gérard ^a,b,c   Merkulova Rainon, Tatyana ^a,b  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Hôpital Lariboisière   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^e INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Angiogenesis; Hepatocellular carcinoma; Molecular targeted therapies; Neuropilin 1; Tumour vascular remodelling; Vascular endothelial growth factor

Indexed keywords

NEUROPILIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL FUNCTION; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TUMOR GROWTH; UPREGULATION; VASCULAR REMODELLING; WESTERN BLOTTING;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILIN-1; PEPTIDES; UP-REGULATION;

EID: 79957918593     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.01.033     Document Type: Article

References (48)

1. J.M. Llovet, and J. Bruix Novel advancements in the management of hepatocellular carcinoma in 2008 J Hepatol 48 2008 S20 S37
2. M. Fernandez, D. Semela, J. Bruix, I. Colle, M. Pinzani, and J. Bosch Angiogenesis in liver disease J Hepatol 50 2009 604 620
3. Z.F. Yang, and R.T. Poon Vascular changes in hepatocellular carcinoma Anat Rec (Hoboken) 291 2008 721 734
4. A.O. Kaseb, A. Hanbali, M. Cotant, M.M. Hassan, I. Wollner, and P.A. Philip Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature Cancer 115 2009 4895 4906
5. M. Thomas Molecular targeted therapy for hepatocellular carcinoma J Gastroenterol 44 2009 136 141
6. I.C. Zachary, P. Frankel, I.M. Evans, and C. Pellet-Many The role of neuropilins in cell signalling Biochem Soc Trans 37 2009 1171 1178
7. D.C. West, C.G. Rees, L. Duchesne, S.J. Patey, C.J. Terry, and J.E. Turnbull Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2 J Biol Chem 280 2005 13457 13464 (Pubitemid 40517234)
8. E. Sulpice, J. Plouet, M. Berge, D. Allanic, G. Tobelem, and T. Merkulova-Rainon Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity Blood 111 2008 2036 2045 (Pubitemid 351451514)
9. S. Banerjee, K. Sengupta, K. Dhar, S. Mehta, P.A. D'Amore, and G. Dhar Breast cancer cells secreted platelet-derived growth factor-induced motility of vascular smooth muscle cells is mediated through neuropilin-1 Mol Carcinog 45 2006 871 880 (Pubitemid 44646339)
10. Y. Glinka, and G.J. Prud'homme Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity J Leukoc Biol 84 2008 302 310 (Pubitemid 351960305)
11. Y. Cao, A. Szabolcs, S.K. Dutta, U. Yaqoob, K. Jagavelu, and L. Wang Neuropilin-1 mediates divergent R-Smad signaling and the myofibroblast phenotype J Biol Chem 285 2010 31840 31848
12. S. Cao, U. Yaqoob, A. Das, U. Shergill, K. Jagavelu, and R.C. Huebert Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells J Clin Invest 120 2010 2379 2394
13. K. Dhar, G. Dhar, M. Majumder, I. Haque, S. Mehta, and P.J. Van Veldhuizen Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1 Mol Cancer 9 2010 209
14. D.R. Bielenberg, C.A. Pettaway, S. Takashima, and M. Klagsbrun Neuropilins in neoplasms: expression, regulation, and function Exp Cell Res 312 2006 584 593 (Pubitemid 43290335)
15. A. Bagri, M. Tessier-Lavigne, and R.J. Watts Neuropilins in tumor biology Clin Cancer Res 15 2009 1860 1864
16. H. Ding, X. Wu, L. Roncari, N. Lau, P. Shannon, and A. Nagy Expression and regulation of neuropilin-1 in human astrocytomas Int J Cancer 88 2000 584 592
17. A. Latil, I. Bieche, S. Pesche, A. Valeri, G. Fournier, and O. Cussenot VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms Int J Cancer 89 2000 167 171 (Pubitemid 30185926)
18. D.E. Hansel, R.E. Wilentz, C.J. Yeo, R.D. Schulick, E. Montgomery, and A. Maitra Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract Am J Surg Pathol 28 2004 347 356 (Pubitemid 38269568)
19. T. Kawakami, T. Tokunaga, H. Hatanaka, H. Kijima, H. Yamazaki, and Y. Abe Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma Cancer 95 2002 2196 2201 (Pubitemid 35253382)
20. Q. Pan, Y. Chanthery, W.C. Liang, S. Stawicki, J. Mak, and N. Rathore Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth Cancer Cell 11 2007 53 67 (Pubitemid 46054517)
21. T.M. Hong, Y.L. Chen, Y.Y. Wu, A. Yuan, Y.C. Chao, and Y.C. Chung Targeting neuropilin 1 as an antitumor strategy in lung cancer Clin Cancer Res 13 2007 4759 4768 (Pubitemid 47294782)
22. M.L. Gagnon, D.R. Bielenberg, Z. Gechtman, H.Q. Miao, S. Takashima, and S. Soker Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: in vivo expression and antitumor activity Proc Natl Acad Sci USA 97 2000 2573 2578 (Pubitemid 30159212)
23. G. Schuch, M. Machluf, G. Bartsch Jr., M. Nomi, H. Richard, and A. Atala In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo Blood 100 2002 4622 4628 (Pubitemid 35429707)
24. G. Bartsch Jr., K. Eggert, S. Soker, C. Bokemeyer, R. Hautmann, and G. Schuch Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma J Urol 179 2008 326 332 (Pubitemid 350216716)
25. A. Starzec, R. Vassy, A. Martin, M. Lecouvey, B.M. Di, and M. Crepin Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1 Life Sci 79 2006 2370 2381 (Pubitemid 44772930)
26. H. Jia, L. Cheng, M. Tickner, A. Bagherzadeh, D. Selwood, and I. Zachary Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity Br J Cancer 102 2010 541 552
27. C. Nasarre, M. Roth, L. Jacob, L. Roth, E. Koncina, and A. Thien Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo Oncogene 29 2010 2381 2392
28. K. Karjalainen, D.E. Jaalouk, C.E. Bueso-Ramos, A.J. Zurita, A. Kuniyasu, and B.L. Eckhardt Targeting neuropilin-1 in human leukemia and lymphoma Blood 117 2011 920 927
29. A. Jarvis, C.K. Allerston, H. Jia, B. Herzog, A. Garza-Garcia, and N. Winfield Small molecule inhibitors of the neuropilin-1 vascular endothelial growth factor A (VEGF-A) interaction J Med Chem 53 2010 2215 2226
30. F. Braet, M. Shleper, M. Paizi, S. Brodsky, N. Kopeiko, and N. Resnick Liver sinusoidal endothelial cell modulation upon resection and shear stress in vitro Comp Hepatol 3 2004 7
31. E. Raskopf, A. Vogt, J. Standop, T. Sauerbruch, and V. Schmitz Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma Z Gastroenterol 48 2010 21 27
32. N. Dubois, M. Bennoun, I. Allemand, T. Molina, G. Grimber, and M. Daudet-Monsac Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice J Hepatol 13 1991 227 239
33. E. Dupuy, P. Hainaud, A. Villemain, E. Bodevin-Phedre, J.P. Brouland, and P. Briand Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model J Hepatol 38 2003 793 802 (Pubitemid 36613346)
34. S. Van de Veire, I. Stalmans, F. Heindryckx, H. Oura, A. Tijeras-Raballand, and T. Schmidt Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease Cell 141 2010 178 190
35. T. Merkulova-Rainon, P. England, S. Ding, C. Demerens, and G. Tobelem The N-terminal domain of hepatocyte growth factor inhibits the angiogenic behavior of endothelial cells independently from binding to the c-met receptor J Biol Chem 278 2003 37400 37408 (Pubitemid 37175259)
36. S. Ding, T. Merkulova-Rainon, Z.C. Han, and G. Tobelem HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro Blood 101 2003 4816 4822 (Pubitemid 36857740)
37. J.M. Stephenson, S. Banerjee, N.K. Saxena, R. Cherian, and S.K. Banerjee Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer Int J Cancer 101 2002 409 414
38. P. Bonnin, A. Villemain, F. Vincent, H. Debbabi, J.S. Silvestre, and J.O. Contreres Ultrasonic assessment of hepatic blood flow as a marker of mouse hepatocarcinoma Ultrasound Med Biol 33 2007 561 570 (Pubitemid 46476827)
39. K. Wallace, A.D. Burt, and M.C. Wright Liver fibrosis Biochem J 411 2008 1 18 (Pubitemid 351482341)
40. R.S. Finn Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now? Clin Cancer Res 16 2010 390 397
41. A.B. Siegel, E.I. Cohen, A. Ocean, D. Lehrer, A. Goldenberg, and J.J. Knox Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma J Clin Oncol 26 2008 2992 2998
42. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
43. L. Xu, D.G. Duda, T.E. di, M. Ancukiewicz, D.C. Chung, and G.Y. Lauwers Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer Cancer Res 69 2009 7905 7910
44. B. Hu, P. Guo, I. Bar-Joseph, Y. Imanishi, M.J. Jarzynka, and O. Bogler Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway Oncogene 26 2007 5577 5586 (Pubitemid 47267840)
45. A. Matsushita, T. Gotze, and M. Korc Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1 Cancer Res 67 2007 10309 10316 (Pubitemid 350070805)
46. S. Zhang, H.E. Zhau, A.O. Osunkoya, S. Iqbal, X. Yang, and S. Fan Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells Mol Cancer 9 2010 9
47. C. Pellet-Many, P. Frankel, H. Jia, and I. Zachary Neuropilins: structure, function and role in disease Biochem J 411 2008 211 226 (Pubitemid 351580173)
48. Y. Herzog, C. Kalcheim, N. Kahane, R. Reshef, and G. Neufeld Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins Mech Dev 109 2001 115 119 (Pubitemid 33035924)